Skip to main content

DARPA Puts Biotech at the Fore

The U.S. Department of Defense is solidifying its focus on the life sciences with a new division of biotechnology.  

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

WIKIMEDIA, DEPARTMENT OF DEFENSEA new division at the U.S. Defense Advanced Research Projects Agency (DARPA) will consolidate the Department of Defense’s biology projects into a Biological Technologies Office (BTO) that will expand upon work already underway at the agency. According to a press release, “DARPA is poised to give unprecedented prominence to a field of research that can no longer be considered peripheral to technology’s evolving nature.”

“Researchers should see this move as a recognition of the enormous potential of biological technologies,” Alicia Jackson, deputy director of the BTO, told ScienceInsider in an e-mail.

Research at DARPA’s Defense Sciences Office and its Microsystems Technology Office will seed the BTO, along with a new Hand Proprioception & Touch Interfaces program. The main lines of study include prosthetics, biological manufacturing, security in bioengineering, and “biochronicity”—a program that “aims to make it possible to manage the effects of time on human physiology,” according to the release. All are aimed at shoring up the nation’s defenses.

“We’ve been developing the technological building blocks, we’ve been analyzing our results, and now we’re saying publicly to the research and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays